491 related articles for article (PubMed ID: 20603314)
21. Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.
Karadimou G; Gisterå A; Gallina AL; Caravaca AS; Centa M; Salagianni M; Andreakos E; Hansson GK; Malin S; Olofsson PS; Paulsson-Berne G
J Intern Med; 2020 Sep; 288(3):321-334. PubMed ID: 32410352
[TBL] [Abstract][Full Text] [Related]
22. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
[TBL] [Abstract][Full Text] [Related]
23. Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
Gonçalves I; Cherfan P; Söderberg I; Nordin Fredrikson G; Jonasson L
Autoimmunity; 2009 Mar; 42(3):203-8. PubMed ID: 19301201
[TBL] [Abstract][Full Text] [Related]
24. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
Yilmaz A; Jennbacken K; Fogelstrand L
BMC Infect Dis; 2014 Mar; 14():143. PubMed ID: 24636004
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
26. Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice.
van Leeuwen M; Kemna MJ; de Winther MP; Boon L; Duijvestijn AM; Henatsch D; Bos NA; Gijbels MJ; Tervaert JW
PLoS One; 2013; 8(7):e68039. PubMed ID: 23874490
[TBL] [Abstract][Full Text] [Related]
27. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
[TBL] [Abstract][Full Text] [Related]
28. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
[TBL] [Abstract][Full Text] [Related]
29. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.
Kimura T; Tse K; McArdle S; Gerhardt T; Miller J; Mikulski Z; Sidney J; Sette A; Wolf D; Ley K
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H781-H790. PubMed ID: 28087520
[TBL] [Abstract][Full Text] [Related]
30. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
Habets KL; van Puijvelde GH; van Duivenvoorde LM; van Wanrooij EJ; de Vos P; Tervaert JW; van Berkel TJ; Toes RE; Kuiper J
Cardiovasc Res; 2010 Feb; 85(3):622-30. PubMed ID: 19819882
[TBL] [Abstract][Full Text] [Related]
31. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.
Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140
[TBL] [Abstract][Full Text] [Related]
32. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals.
Huang YH; Rönnelid J; Frostegård J
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1577-83. PubMed ID: 7583530
[TBL] [Abstract][Full Text] [Related]
33. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.
Scapini P; Hu Y; Chu CL; Migone TS; Defranco AL; Cassatella MA; Lowell CA
J Exp Med; 2010 Aug; 207(8):1757-73. PubMed ID: 20624892
[TBL] [Abstract][Full Text] [Related]
34. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.
Kyaw T; Cui P; Tay C; Kanellakis P; Hosseini H; Liu E; Rolink AG; Tipping P; Bobik A; Toh BH
PLoS One; 2013; 8(4):e60430. PubMed ID: 23560095
[TBL] [Abstract][Full Text] [Related]
35. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
Caligiuri G; Nicoletti A; Poirier B; Hansson GK
J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
[TBL] [Abstract][Full Text] [Related]
37. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice.
Major AS; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1892-8. PubMed ID: 12426221
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.
Wilhelm AJ; Zabalawi M; Grayson JM; Weant AE; Major AS; Owen J; Bharadwaj M; Walzem R; Chan L; Oka K; Thomas MJ; Sorci-Thomas MG
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):843-9. PubMed ID: 19286630
[TBL] [Abstract][Full Text] [Related]
39. Impaired Autophagy in CD11b
Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
[TBL] [Abstract][Full Text] [Related]
40. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
